ArticleJGH open : an open access journal of gastroenterology and hepatology2021

Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S-1 as second-line chemotherapy in metastatic pancreatic cancer.

Kenji Ikezawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.